Avantax Advisory Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,193
| Closed | -$300K | – | 1575 |
|
|
2023
Q2 | $300K | Sell |
6,193
-460
| -7% | -$22.3K | ﹤0.01% | 1186 |
|
|
2023
Q1 | $328K | Hold |
6,653
| – | – | ﹤0.01% | 1104 |
|
|
2022
Q4 | $337K | Sell |
6,653
-10
| -0.2% | -$506 | ﹤0.01% | 1043 |
|
|
2022
Q3 | $334K | Buy |
6,663
+1,385
| +26% | +$69.4K | 0.01% | 951 |
|
|
2022
Q2 | $258K | Buy |
+5,278
| New | +$258K | ﹤0.01% | 1083 |
|